XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 25, 2021   29,837,454      
Balance at beginning of period at Dec. 25, 2021 $ (309,525) $ 299 $ 463 $ (310,031) $ (256)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 8,676     8,676  
Shares issued under stock plans (in shares)   41,289      
Shares issued under stock plans 125   125    
Tax payments for restricted stock upon vesting (in shares)   (1,923)      
Tax payments for restricted stock upon vesting (298)     (298)  
Stock-based compensation expense 2,191   2,191    
Dividends declared on common stock and equivalents (125,330)   (2,370) (122,960)  
Currency translation adjustment (66)       (66)
Balance at end of period (in shares) at Mar. 26, 2022   29,876,820      
Balance at end of period at Mar. 26, 2022 $ (424,227) $ 299 409 (424,613) (322)
Balance at beginning of period (in shares) at Dec. 31, 2022 29,932,668 29,932,668      
Balance at beginning of period at Dec. 31, 2022 $ (390,861) $ 300 2,797 (393,321) (637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 15,669     15,669  
Shares issued under stock plans (in shares)   49,817      
Shares issued under stock plans 111   111    
Tax payments for restricted stock upon vesting (in shares)   (13,613)      
Tax payments for restricted stock upon vesting (2,292)     (2,292)  
Stock-based compensation expense 3,345   3,345    
Dividends declared on common stock and equivalents (5,909)   (5,444) (465)  
Currency translation adjustment $ 147       147
Balance at end of period (in shares) at Apr. 01, 2023 29,968,872 29,968,872      
Balance at end of period at Apr. 01, 2023 $ (379,790) $ 300 $ 809 $ (380,409) $ (490)